Filter
137
Text search:
biontech
Featured
Recommendations
27
Language
Document type
Guidelines
50
Fact sheets
30
Studies & Reports
24
Manuals
10
Strategic & Response Plan
5
Training Material
4
Resource Platforms
4
Infographics
4
Online Courses
3
Situation Updates
2
Brochures
1
Countries / Regions
Germany
9
Brazil
9
Russia
8
Argentina
7
Ukraine
6
Middle East and North Africa
5
South Africa
4
Mozambique
4
Latin America and the Carribbean
4
Paraguay
4
China
3
Ecuador
3
Chile
3
Colombia
2
Angola
2
Global
2
Nigeria
1
Senegal
1
Guinea-Bissau
1
Philippines
1
Somalia
1
South Sudan
1
Syria
1
Sudan
1
Peru
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Africa
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
61
Key Resources
3
Annual Report MEDBOX
1
Clinical Guidelines
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
117
Refugee
9
TB
2
Health Financing Toolbox
2
Ebola
1
Conflict
1
10 December 2020
Vaccine handling, storage and Transportation of Pfizer BioNTech
COVID-19 COMIRNATY® (Tozinameran)
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be trans
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab
...
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
временные рекомендации от 8 января 2021 г.
Available in Arabic, Chinese, English, French, Russian and Spanish here: https://apps.who.int/iris/handle/10665/338484
обновленная версия от 04/10/2021
Информация о введении вакцин
updated version: 04/10/2021
Information about vaccine administration
Information about vaccine administration
Stand 1.12.2020
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc
...
